IRCT2016121725031N6
Completed
未知
Evaluating the Effectiveness of Memantine as Adjuvant Treatment on the Symptoms of Acute Mania in the Patients with Bipolar 1 Disorder
Vice Chancellor for Research of Arak University of Medical Sciences0 sites90 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Bipolar I disorder.
- Sponsor
- Vice Chancellor for Research of Arak University of Medical Sciences
- Enrollment
- 90
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Between 18 to 60 years old; Meet the criteria for bipolar disorder based on DSM\-1V\-TR diagnostic criteria and clinical interview by a psychiatrist; Existence of mania, with a minimum score of 20 in Young Mania Rating Scale; Lack of psychiatric diseases; Without mental retardation; Lack of any disease that make a problem in the clinical study; Do not consume narcotic, stimulants and alcohol except nicotine in the three last months; Do not electroconvulsive therapy in the previous month; Not pregnant; Without drug allergy and drug side effects history on the this study drugs; Do not consume memantine in the three last months; Lack of dementia, delirium, cognitive disorders and epilepsy. Exclusion criteria: Drugs side effect that causing discontinuation of consume them; Request by the patient or the patient's parent or legal guardian to withdraw from the study at any time of the study; Consume of alcohol or narcotic by the patient after starting the study; Lack of response to the drug therapy after 2 weeks.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Memantine for treatment of Obsessive-Compulsive DisorderIRCT20170123032145N4Iran University of Medical Sciences44
Recruiting
Phase 2
Study of the efficacy of memantine in metastatic colon canceIRCT20210819052230N1Oroumia University of Medical Sciences50
Completed
Phase 2
Memantine effect in the treatment of residual symptoms in patients with schizophreniaIRCT2017013032236N2Vice chancellor for research, Mazandaran University of Medical Sciences50
Completed
Phase 2
The efficacy of complementory use of memantine in treatment of schizophrenia with chronic courseSchizophrenia.SchizophreniaIRCT201306015605N1Clinical psychiatry research center, Tabriz university of medical sciences60
Completed
Not Applicable
Efficacy of Memantine in bipolarBipolar disorder.Bipolar affective disorderIRCT2013091514676N1Vice chancellor for research, Kurdistan University of Medical Sciences40